genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
ImmunoGen
Cancer
AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise
GEN Edge
StockWatch: Illumina Stays Mum as Short Seller Targets Icahn
New Products
Centrifugal Evaporator
Featured
Antibodies and Antibody-Drug Conjugate Higher Order Structures Revealed
Cancer
Study Shows Universal Sequencing Detects More Cancer Mutations
Industry News
Evoke Pharma Lead Candidate EVK-001 Fails Phase III Trial
Industry News
Forum Pharmaceuticals to Restructure after Phase III Failures
Cancer
Takeda Joins ImmunoGen to Co-Develop Cancer ADCs in $440M+ Partnership
Insights
Osiris Trumpets Its Adult Stem Cell Product
News
ImmunoGen Regains Exclusive License to Anticancer Agent from Centocor
Scroll Up
Scroll Up
